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Abstract
Background: The current study aims to compare the application and convenience of the upper arm port with the
other two methods of implanted ports in the jugular vein and the subclavian vein in patients with gastrointestinal
cancers.
Methods: Currently, the standard of practice is placement of central venous access via an internal jugular vein
approach. Perioperative time, postoperative complications, and postoperative comfort level in patients receiving an
implanted venous port in the upper arm were retrospectively compared to those in the jugular vein and the
subclavian vein from April 2013 to November 2014.
Results: Three hundred thirty-four patients are recruited for this analysis, consisting of 107 in the upper arm vein
group, 70 in the jugular vein group, and 167 in the subclavian vein group. The occurrence of catheter
misplacement in the upper arm vein is higher than that in the other two groups (13.1 vs. 2.9 vs. 5.4 %, respectively,
P = 0.02), while the other complications in the perioperative period were not significantly different. The occurrence
of transfusion obstacle of the upper arm vein group is significantly lower than that of the jugular and subclavian
groups (0.9 vs. 7.1 vs. 7.2 %, P = 0.01). The occurrence of thrombus is also lower than that of other two groups
(0.9 vs. 4.3 vs. 3.6 %, P = 0.03). Regarding the postoperative comfort, the influences of appearance (0 vs. 7.1 vs. 2.9 %,
P = 0.006) and sleep (0.9 vs. 4.2 vs. 10.7 %, P = 0.003) are significantly better than those of the jugular and subclavian
vein groups.
Conclusions: Compared to the jugular and the subclavian vein groups, the implanted venous port in the upper
arm vein has fewer complications and more convenience and comfort, and might be a superior novel choice for
patients requiring long-term chemotherapy or parenteral nutrition.
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Background
The incidences of gastrointestinal cancers are increasing.
Most of the patients require long-term chemotherapy or
have to receive 5-fluorouracil-based chemotherapy. There-
fore, more and more patients need a central venous
catheter in order to protect the peripheral vein. Totally
implantable central venous ports (CVP) comprise all the
devices embedded in the subcutaneous tissue, protected
by skin. CVP with the minimum limit to daily life applies
to patients requiring long-term repeated venipuncture,
chemotherapy, parenteral nutrition support, and transfu-
sion [1].
The jugular vein and the subclavian vein are com-
monly selected with the injection base embedded under
the clavicle and chest skin. However, these two methods
carry a risk of puncture resulting to pneumothorax,
hemothorax, and artery injury [2, 3]. Currently, the
standard of practice is placement of central venous
access via an internal jugular vein approach. The arm
port is a novel implanted port method, which only
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requires selecting the basilica vein or brachial vein,
guided by vessel B ultrasonic set, for puncture by im-
proved Seldinger puncture technique in the peripher-
ally inserted central catheter (PICC) room. This
method solely requires a professional nurse for vein
therapy with PICC catheterizing qualification for op-
eration under the doctor’s supervision. The whole
procedure is simple and avoids occupancy of the op-
erating room. Any large cohort of patients undergoing
the new method has not been widely reported. The
current study aims to compare the operation time,
occurrence of postoperative complications, and pa-
tient comfort of the upper arm port with the other
two methods of implanted ports in the jugular vein




A retrospective analysis was conducted for patients re-
ceiving implantation of three different access ports in
The Sixth Affiliated Hospital of Sun Yat-sen University,
Medical Oncology, from April 2013 to November 2014.
All of these patients were pathologically diagnosed with
gastrointestinal cancer. Follow-up starts from the day of
port implantation until the day of removal for any rea-
sons or patients’ death. Admission criteria are as follows:
(1) all the patients should be more than 18 years, with
malignant tumor confirmed pathologically; (2) examin-
ation of the patients heart, liver, kidney, and blood
should be normal; (3) patients should have chemothera-
peutic indications without chemotherapeutic and venous
catheterization contraindications; and (4) the arm
circumference for implantation port on the arm should
be ≥25 cm. Exclusion criteria are as follows: (1) any
patient who has been confirmed or suspected of infec-
tion, bacteremia, or blood poisoning; (2) patients with
too small body size to accept implantation equipment;
(3) patients with chronic obstructive pulmonary disease;
and (4) patients with radiotherapy, trauma, and surgery
at the operative site. This study was approved by the in-
stitutional review board of The Sixth Affiliated Hospital,
Sun Yat-sen University (Guangzhou, Guangdong), and
written informed consent was obtained from every
participant.
Device for access port
The device for access port is 6F fine implanted port suite
manufactured by US Bard Co., Ltd. with a catheter
length of 75 cm, and the device for the jugular venous
and subclavian venous ports is 7.5F implanted access
port suite manufactured by Braun Medical Co., Ltd. with
a catheter length of 50 cm.
Implantation of access port
Implantation of access port should be conducted with
local anesthesia. Access port on the arm should be im-
planted by two professional nurses with PICC implant-
ation qualification. Basilica or cephalic vein of the upper
right arm is selected for puncture guided by the color
vessel Doppler ultrasound with improved Seldinger
puncture technique. Subsequent to catheter implant-
ation, routine chest X-ray should be examined for the
feeding of the catheter and the position of the tip. If the
catheter reverses or the tip position is abnormal, it
should be readjusted with the aid of X-rays. Under a
physician’s guidance, the nurses transect the skin about
3 cm with the center of the puncture point to split the
subcutaneous tissue for the capsular bag and embed the
port foundation under the skin of the upper arm without
establishing the subcutaneous tunnel.
Jugular venous access and subclavian venous access
ports should be implanted by qualified physicians into
the right jugular vein or subclavian vein with puncture
point 2 cm below the middle point between the right
cleidomastoid sternal branch and top or right clavicle at
the clavicle angle. After implanting the catheter, a sub-
cutaneous tunnel is established on the right chest wall.
Subsequently, a routine chest X-ray film is examined for
the feeding and the catheter position.
Maintenance and follow-up of catheter
Fluid can be injected after implanting the access port.
Intact butterfly needle is used to puncture into the port
foundation after skin disinfection. Normal saline is used
to wash the catheter to detect an obstacle and subcuta-
neous seepage in the catheter. When consecutive infu-
sion is required, intact butterfly needle should be
replaced every week. Upon completion of the infusion
therapy, 10 ml heparin saline (100 IU/ml) is used to
wash the catheter. If the catheter cannot be used for
more than 4 weeks, it should be washed in the hospital
every 4 weeks. Follow-up starts from the port implant-
ation until the removal surgery, and the withdrawal date
should be treated as the final usage date of the infusion
port.
Collection of complications
Major observation indices refer to the perioperative time
of three different access ports (the date of port implant-
ation) and incidence rates of postoperative complications
by recording the types and the time of complication in-
cidence. The complications in the perioperative period
include catheter misplacement, pneumothorax, hemo-
thorax, artery injury, and failed puncture, which requires
a change of the puncture path. The postoperative com-
plications include infection, thrombogenesis, poor trans-
fusion, catheter breakage, pinch-off syndrome, seepage
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on foundation, and foundation exposure. The investiga-
tion of postoperative comfort is carried out in a subse-
quent visit (after 15 days); nurses who do not attend this
study inquire and record the patient’s appearance effects,
concerns about catheter breakage, and effect on sleep
and daily life.
Statistical method
Perioperative time, postoperative complications, and
postoperative comfort level in patients receiving an im-
planted venous port in the upper arm were retrospect-
ively compared to those in the jugular vein and the
subclavian vein. The statistical software is SPSS19.0.
Statistical data is represented as a mean ± standard
deviation. ANOVA is used for mean comparison, and
LSD of post hoc inspection is used for the comparison
of two averages. Chi-squared test is used to compare the
complication incidence. P < 0.05 is considered statisti-
cally significant.
Results
General condition of the patients
The analysis recruited 344 patients, including 107 pa-
tients in the upper arm vein group, 70 in the jugular
vein group, and 167 in the subclavian vein group. Table 1
shows the clinical characteristics of patients in the three
groups, with similar basic information. In the three
groups, the average follow-up durations were 257.6 ±
134.1, 307.9 ± 134.3, and 253.4 ± 152.8 days (p = 0.03),
and seven, two, and nine patients failed the follow-up,
respectively.
Complications in ports in the perioperative period
The patients in all the groups have successfully received
port implantation. Patients in the three groups prefer
right implantation. Complications in the operation include
catheter misplacement, pneumothorax, hemothorax, ar-
tery injury, and failed puncture or catheterizing, which
requires changing puncture access. The upper vein group
should take the left upper vein access, while the jugular
and subclavian vein groups should take the subclavian ac-
cess and jugular access, respectively, because of failed
puncture or catheterizing. The incidence of catheter mis-
placement in the upper arm vein group is higher than that
of the other two groups (13.1 vs. 2.9 vs. 5.4 %, P = 0.02),
while the other complications in the perioperative period
do not alter significantly, as shown in Table 2.
Postoperative complications
Table 3 shows complications after port implantation.
Any differences in the complications of foundation ex-
posure, seepage in the foundation, infection, and
thrombus among the three groups were not observed.
However, the incidence of poor transfusion in the upper
vein group is significantly lower than that in the jugular
and subclavian vein groups (0.9 vs. 7.1 vs. 7.2 %, P =
0.01), and its incidence of thrombus was also lower (0.9
vs. 4.3 vs. 3.6 %, P = 0.03); 3, 5, and 13 patients required
the removal of the port because of complications, without
any statistical significance (P = 0.23).
Postoperative comfort after port implantation
The comparison of postoperative comfort shows that
the appearance concern (0 vs. 7.1 vs. 2.9 %, P = 0.006)
and the sleep influence (0.9 vs. 4.2 vs. 10.7 %, P = 0.003)
in the upper arm vein group were not significant as
compared to those in the jugular and subclavian vein
groups (Table 4).
Discussion
The current study compared the application of the
upper arm venous port, the jugular venous port, and the







Patients 107 70 167
Age (years) 54.4 ± 12.3 53.8 ± 13.0 53.0 ± 13.3
Sex
Male 64 (59.8) 41 (58.6) 104 (62.3)
Female 43 (40.2) 29 (41.4) 63 (37.7)
Primary tumor
Colon cancer 33 (30.8) 31 (44.3) 66 (39.5)
Rectal cancer 52 (48.6) 31 (44.3) 84 (50.3)
Gastric cancer 12 (11.2) 7 (10.0) 13 (7.8)
Pancreatic cancer 2 (1.9) 1 (1.4) 0 (0)
Small intestinal carcinoma 1 (0.9) 0 (0) 0 (0)
Esophageal cancer 1 (0.9) 0 (0) 3 (1.8)
Bile duct carcinoma 1 (0.9) 0 (0) 0 (0)
Hepatic carcinoma 1 (0.9) 0 (0) 0 (0)
Others 4 (3.7) 0 (0) 1 (0.6)
Follow-up duration (days) 257.6 ± 134.1 307.9 ± 134.3 253.4 ± 152.8
Data in parenthesis is a percentage








Catheter misplacement 14 (13.1) 2 (2.9) 9 (5.4) 0.02
Pneumothorax 0 (0) 1 (1.4) 2 (1.2) 0.50
Hemothorax 0 0 0
Artery injury 1 (0.9) 4 (5.9) 6 (3.6) 0.18
Change of puncture
access
10 (9.3) 3 (4.3) 9 (5.4) 0.31
Data in parenthesis is a percentage
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subclavian venous port in patients with malignant
tumor. The result shows that there is no significant dif-
ference in the perioperative period among the three
groups. While the incidence of the postoperative compli-
cations in the upper arm venous group is lower, the
comfort level is higher.
Implantation of the upper arm port is conducted in
the PICC catheterizing room; hence, the catheter feeding
and tip position cannot be determined during the oper-
ation. Moreover, because the catheterizing route is elon-
gated, it is easy to mislead the feeding to the jugular
vein, thus reversing the catheter, or catheterizing deeply
into the heart to cause discomfort in the neck or precor-
dial area. Therefore, we measure the distance between
the planned puncture point and the sternum midpoint
in a preoperative routine as the reference depth of
catheterization during operation. Meanwhile, routine
inspection with a chest X-ray film is conducted to distin-
guish the catheter feeding and tip position after cathe-
terizing, rather than cutting the skin to implant the
foundation. If the catheter position is abnormal, the ad-
justment should be conducted under the X-ray machine.
Although the incidence of catheter misplacement is high
(13.1 %) in the upper arm vein group, the position can
be adjusted to normal under perspective. Also, without a
subcutaneous tunnel, the complication of poor transfu-
sion is also lower than that in the jugular and subclavian
groups (P = 0.06). The lumen of the upper arm vein is
remarkably small, such that the puncture failure rate
was reported to be 5–11 % [4, 5], and the ratio of chan-
ging puncture access in this group was 9.3 %. Kawamura
et al. [6] assessed the implantation of the upper arm port
in 113 patients with metastatic colorectal cancer receiv-
ing chemotherapy. All the patients received puncture
under the guidance of real-time ultrasound or radiation,
and none of them demonstrated complications in the
perioperative period; only nine patients showed postop-
erative complications (8.0 %). It was concluded that the
upper arm port exhibited favorable short- and long-term
effects.
The upper arm port access can completely avoid
severe puncture complications, such as pneumothorax
and hemothorax, and only one patient had artery injury
(0.9 %). The blind puncture was conducted in the jugu-
lar and subclavian vein groups, which is greatly influ-
enced by the experience of operators and individual
anatomic differences. Thus, the probability of pneumo-
thorax (0.3–3.2 %) [7, 8] and artery injury is high. The
incidence of catheter misplacement is low when choos-
ing the jugular vein as the puncture access, but is simple
to distort and narrow for the catheter to cause poor
transfusion. Since the injection foundation is embedded
on the upper wall, the catheter should be downward
feeding after turning 180° and the subcutaneous tunnel
elongated. Moreover, the tractive feeling in the neck
after the operation is obvious, lowering the comfort
level. The subcutaneous tunnel in the subclavian venous
access is short. Thus, the patients have no tractive feel-
ing in the neck. However, severe complications, such as
pneumothorax, hemothorax, mediastinum hematoma,
and pinch-off syndrome may occur in the puncture to
cause catheter breakage [9, 10]. When the catheter
passes through the interval between the clavicle and the
first rib, poor transfusion, thrombus, breakage, and per-
foration may occur, and the catheter may even rupture
because of pressure. The broken end may flow into the
heart or lung along with the blood flow to cause
arrhythmia or pulmonary embolism. In this study, three
patients had a pinch-off syndrome in the subclavian vein
group (1.8 %), including two patients requiring emer-
gency surgery for the removal of the broken end due to
catheter fracture.
In the postoperative complications, the incidence of
infection in the upper arm vein group (0.9 %) is lower
than that in the jugular vein group and subclavian vein
group. The study did not record any significant differ-
ence in the infection rates of arm port and subclavian
venous port [11, 12]. In the long-term maintenance of
ports, phlebothrombosis is another severe complication.
Patients and port implantation may increase the risk of
phlebothrombosis [13]. The retrospective study shows
that the incidence of thromboembolism related to the








Foundation exposure 2 (1.9) 1 (1.4) 0 (0) 0.23
Seepage on foundation 1 (0.9) 1 (1.4) 1 (0.6) 0.82
Thrombus 1 (0.9) 3 (4.3) 6 (3.6) 0.03
Infection 1 (0.9) 2 (2.9) 6 (3.6) 0.40
Poor transfusion 1 (0.9) 5 (7.1) 12 (7.2) 0.01
Catheter breakage 0 (0) 0 (0) 2 (1.2) 0.34
Pinch-off syndrome 0 (0) 0 (0) 3 (1.8) 0.20
Patients with pump
removal
3 (2.8) 5 (7.1) 13 (7.8) 0.23
Data in parenthesis is a percentage









Appearance 0 (0) 5 (7.1) 5 (2.9) 0.006
Concern of catheter
breakage
3 (2.8) 4 (5.7) 18 (10.7) 0.19
Sleep influence 1 (0.9) 3 (4.2) 18 (10.7) 0.003
Influence on daily life 0 (0) 0 (0) 2 (1.1) 0.26
Data in parenthesis is percentage
Li et al. World Journal of Surgical Oncology  (2016) 14:251 Page 4 of 6
catheter is up to 12–64 %, but the anticoagulant for rou-
tine prevention is not recommended [14], even though
one study indicates that the incidence of deep venous
thrombosis in the arm port is higher than that in the
chest port [15].
The other significant advantages of the upper arm port
are that the postoperative comfort level and life quality
of patients are high. The foundation embedded in the
upper arm is concealed, and the invisibility of the punc-
ture point and operation scar in the neck and chest
renders it esthetically applicable for patients.
Moreover, in fluid replacement therapy, patients do
not require upper body undressing, which avoids embar-
rassment and discomfort, especially in women [6]. Goltz
et al. [16] found that the satisfaction and life quality of
patients receiving arm port implantation were signifi-
cantly higher than those of chest port implantation.
Compared with the forearm port, the upper arm port
has no difference in the infection rate, deep venous
thrombosis, catheter misplacement, or stoppage. The
embedded position of an upper arm port is high; short
sleeves can cover the injection foundation without the
subcutaneous tunnel, through chelidon. Therefore, we
think the patients’ quality of life with the upper arm port
is better.
The limitation of this study is that the type assessment
of perioperative period and postoperative complications
in the retrospective analysis is not quite comprehensive.
Moreover, this is a study conducted by a single center,
and patients in the three groups are not randomized.
Also, the learning curve should be accomplished at an
early stage after introducing the upper arm port into the
hospital, to prevent the high incidences of catheter mis-
placement. However, few relevant studies on the upper
arm are conducted in China, but several occur abroad.
The current study provided evidence to assess the safety
of clinical application of the upper arm port.
Conclusions
In conclusion, the operation of the upper arm venous
port is safe such that severe puncture complications,
such as pneumothorax, hemothorax, and pinch-off syn-
drome, are avoided. The incidence of postoperative com-
plications is lower than that in jugular venous access
port and subclavian access port, and the discomfort level
and patients’ quality of life is better. Therefore, the
upper arm venous port implantation method might be a
good choice in clinical applications.
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